DE vs JNJ: Which Is the Better Buy?
Side-by-side comparison of Deere & Company and Johnson & Johnson โ fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-25.
Deere & Company ยท Industrials
$703.12
-12.2% upside to fair value
Med Conviction
Grade C
High Quality
VS
Johnson & Johnson ยท Healthcare
$270.68
+5.7% upside to fair value
Med Conviction
Grade C
High Quality
QuantHub Verdict
JNJ has more upside to fair value
(+5.7%).
These are model outputs โ not personalized investment advice.
See all research โ
Valuation & Fundamentals
| Metric |
DE |
JNJ |
| Current Price |
$703.12 |
$270.68 |
| Fair Value Estimate |
$616.99 |
$286.05 |
| Upside to Fair Value |
-12.2%
|
+5.7%
|
| Market Cap |
$189.8B |
$652.3B |
| Forward P/E |
โ
|
โ
|
| EV / EBITDA |
22.1x
|
20.2x
|
| Price / Sales |
4.0x
|
6.7x
|
| Price / FCF |
49.1x
|
35.3x
|
| Revenue Growth YoY |
+7.0%
|
+6.6%
|
| Gross Margin |
35.7%
|
67.9%
|
| Operating Margin |
19.0%
|
26.8%
|
| Return on Equity |
18.1%
|
25.7%
|
| Dividend Yield |
0.92% |
1.95% |
| FCF Yield |
2.04%
|
2.83%
|
| Analyst Consensus |
Buy
|
Buy
|
Investment Thesis
Deere & Company is a 1837-founded global manufacturer of agricultural, turf, and construction equipment organized across Production and Precision Agriculture, Small Agriculture and Turf, Construction and Forestry, and Financial Services, employing roughly 73,100 people under CEO John C. May. Business quality is high on franchise strength but currently strained by the large-agriculture cycle: TTM โฆ
Johnson & Johnson is a 141,700-employee healthcare holding company operating two segments, Innovative Medicine (immunology, oncology, neuroscience, infectious disease, cardiovascular and metabolism, pulmonary hypertension) and MedTech (interventional solutions, orthopaedics, surgery, vision), founded in 1887 and headquartered in New Brunswick, New Jersey. Business quality is high on fundamentals:โฆ
Accumulation Zones
| Metric |
DE |
JNJ |
| Zone Low |
$462.74 |
$214.54 |
| Zone High |
$524.44 |
$243.14 |
| In Buy Zone? |
No
|
No
|